24 reports

The generic drugs market was valued at USD 364,925.27 million in 2021, and it is expected to reach USD 468,787.86 million by 2027, registering a CAGR of 4.27% during the forecast period of 2022-2027. During the early pandemic, COVID-19 has severly impacted the generic drugs market due to the lockdown restrictions and supply chain disruption....

  • Generic Drug
  • World
  • Health Expenditure
  • Gross Domestic Product

Generic Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID 19 shut down. Description: Where...

  • Generic Drug
  • World
  • Gross Domestic Product Per Capita
  • Health Expenditure

United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the...

  • Generic Drug
  • United States
  • Generics Use
  • Health Expenditure

The US generic injectables market reached a value of US$ 16.3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 29.6 Billion by 2027, exhibiting a CAGR of 10.21% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Healthcare
  • In-Store Retail
  • Arthritis
  • Transportation
  • Generic Drug
  • United States
  • Health Expenditure

Generic Drugs Market Report 2020-2030: Growth in Leading Regional and National Markets (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan,...

  • Generic Drug
  • World
  • APAC
  • Health Expenditure
  • Generics Use

Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug...

  • Generic Drug
  • Canada
  • Health Expenditure
  • Chronic Disease Prevalence

Global Eye Infections Therapeutics Market: About this market This eye infections therapeutics market analysis considers sales from conjunctivitis, keratitis, blepharitis, and other eye infections types. Our analysis also considers the sales of eye infections therapeutics in Asia, Europe, North America, and ROW. In...

  • Therapy
  • Generic Drug
  • World
  • Generic Drugs Market Share
  • Health Expenditure

On the mend: Operators will likely lobby for policies that encourage access to affordable medicines Abstract Generic Pharmaceutical Manufacturing in the US The Generic Pharmaceutical Manufacturing industry is expanding at a steady pace, with revenue expected to increase over the five years to 2019....

  • Generic Drug
  • United States
  • Employment Income
  • Pharmaceutical Production

Take one: More generic drugs are expected to enter the market, boosting industry revenue Abstract Generic Pharmaceutical Manufacturing in Canada Over the past five years, generic prescriptions have accounted for a larger share of total prescriptions dispensed by volume. According to data from the Canadian...

  • Generic Drug
  • Canada
  • Employment Income
  • Pharmaceutical Production

Full attention: As the economy recovers from the pandemic, industry revenue will rebound Abstract ADHD Medication Manufacturing The ADHD Medication Manufacturing industry has exhibited steady growth over the five years to 2019, driven by the continued growth in the incidence of ADHD. However, revenue...

  • Neurological Disorder
  • Health Insurance
  • Generic Drug
  • Research And Development
  • Private Health Insurance
  • United States
  • Pharmaceutical Production
  • Employment Income

Digital Dose Inhaler Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Digital Dose Inhaler Market Size, Outlook and Growth Opportunities to 2025: By Product( Metered Dose Inhaler, and Dry Powder Inhaler), By Type( Branded Medication, and Generic Medication), and By Region Digital Dose Inhaler...

  • Healthcare
  • Generic Drug
  • Pulmonary Delivery
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Pharmer’s market: The continued move toward generic drugs will further depress revenue growth Abstract Drug, Cosmetic & Toiletry Wholesaling in Florida Over the five years to 2017, the Drug, Cosmetic and Toiletry Wholesaling industry in Florida has experienced moderate, but hesitant, expansion as...

  • Wholesaling
  • Prescription Drug
  • Generic Drug
  • Health Insurance
  • Managed Care
  • United States
  • Disposable Income
  • Employment Income

A generic drug is a pharmaceutical product that is generally intended to be interchangeable with an innovator or a branded drug. Generics are manufactured without a licence from the innovator company and are identical or bio-equivalent to an innovator drug in dosage form, safety, strength, route of administration, quality,...

  • Generic Drug
  • World
  • Health Expenditure
  • Spending On Medicines

Abstract Generic Pharmaceutical Manufacturing in Massachusetts Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and...

  • Generic Drug
  • Private Health Insurance
  • Pharmaceutical Production
  • Employment Income

KEY FINDINGS The North America opioid induced constipation drug market is expected to be the fastest growing market during the forecast period of 2017-2025 with an expected CAGR growth of 5.72%. The revenue generated by the market is expected to increase from $840.4 million in 2016 and reach $1382.73 million by 2025. MARKET...

  • OTC
  • Healthcare
  • Generic Drug
  • Digestive System Disorder
  • Gastrointestinal Drug
  • North America
  • Health Expenditure

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent...

  • Pharmaceutical
  • Generic Drug
  • Drug Development
  • APAC
  • World
  • China
  • Japan
  • India
  • Generics Use
  • Generic Drugs Market Share

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers don't have the investment costs of the developer of a new drug. New drugs are developed under patent protection. The...

  • Pharmaceutical
  • Generic Drug
  • United States
  • Drug Approval
  • Health Expenditure

The genitourinary drugs market is expected to reach USD 29.7 billion by 2024, according to a new study by Grand View Research, Inc. This sector is expected to be driven by high R&D investments undertaken by the key companies, which is expected to result in the large-scale development of new drug candidates. This is presumed to increase the...

  • Drug Development
  • Healthcare
  • Proteomics
  • Cancer Immunotherapy
  • Clinical Research
  • Targeted Therapy
  • Generic Drug
  • Genitourinary System Disease
  • World
  • Health Expenditure

The Future of Generic Drugs and Strategies for Commercial Success Summary Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded...

  • Generic Drug
  • World
  • Generics Use
  • Drug Approval

The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative growth of this market include the continually increasing elderly population and the surging prevalence of chronic respiratory diseases. As...

  • Healthcare
  • Medical Device
  • Respiratory Device
  • Respiratory Disease
  • Generic Drug
  • Pulmonary Delivery
  • APAC
  • United States
  • Elderly Population
  • Generics Use

Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese...

  • Pharmaceutical
  • Generic Drug
  • Japan
  • Health Expenditure
  • Out Of Pocket Expenditure

Generics drugs are bioequivalent versions of the originator medicines. These drugs are cheaper and offer similar health benefits as those of branded counterparts. Generics are showing high penetration in the pharma market across the globe. In India, these drugs account for nearly 75% of the pharma market. This is due to the factors, such as...

  • Generic Drug
  • India
  • Health Expenditure

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs...

  • Generic Drug
  • Pharmaceutical
  • Japan
  • Elderly Population
  • Generic Drugs Market Share

The US is the largest pharmaceutical market in the world. Driven by the factors such as large healthcare spending, high per-capita income, and strong research & development investments, the pharmaceutical market in the US has witnessed an upward surge over the past few years. Additionally, the share of Generics has increased steadily in the...

  • Pharmaceutical
  • Generic Drug
  • United States
  • Health Expenditure
  • Generic Drugs Market Share